Bioventix PLC (LON:BVXP – Get Free Report) insider Bruce Hiscock acquired 11 shares of the firm’s stock in a transaction dated Monday, April 29th. The shares were purchased at an average price of GBX 4,552 ($57.18) per share, for a total transaction of £500.72 ($628.97).
Bioventix Price Performance
Shares of BVXP opened at GBX 4,325 ($54.33) on Thursday. The firm has a market cap of £225.77 million, a P/E ratio of 2,653.37 and a beta of 0.36. Bioventix PLC has a 1 year low of GBX 3,402 ($42.73) and a 1 year high of GBX 5,100 ($64.06). The company has a 50 day simple moving average of GBX 4,629.62 and a two-hundred day simple moving average of GBX 4,315.36.
Bioventix Cuts Dividend
The business also recently declared a dividend, which was paid on Friday, April 26th. Shareholders of record on Thursday, April 11th were issued a GBX 68 ($0.85) dividend. The ex-dividend date of this dividend was Thursday, April 11th. This represents a yield of 1.48%. Bioventix’s dividend payout ratio is currently 9,693.25%.
About Bioventix
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Featured Articles
- Five stocks we like better than Bioventix
- What Are the FAANG Stocks and Are They Good Investments?
- AMD is Down 35%. Now is the Time to Buy the Dip
- What is a Bond Market Holiday? How to Invest and Trade
- Amazon Stands Tall: New Highs Are in Sight
- Consumer Staples Stocks, Explained
- Chesapeake Energy Stock is The Energy Play, Earnings Confirm
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.
